140 related articles for article (PubMed ID: 38227031)
1. Analysis of Breast Cancer Mortality in the US-1975 to 2019.
Caswell-Jin JL; Sun LP; Munoz D; Lu Y; Li Y; Huang H; Hampton JM; Song J; Jayasekera J; Schechter C; Alagoz O; Stout NK; Trentham-Dietz A; Lee SJ; Huang X; Mandelblatt JS; Berry DA; Kurian AW; Plevritis SK
JAMA; 2024 Jan; 331(3):233-241. PubMed ID: 38227031
[TBL] [Abstract][Full Text] [Related]
2. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
Plevritis SK; Munoz D; Kurian AW; Stout NK; Alagoz O; Near AM; Lee SJ; van den Broek JJ; Huang X; Schechter CB; Sprague BL; Song J; de Koning HJ; Trentham-Dietz A; van Ravesteyn NT; Gangnon R; Chandler Y; Li Y; Xu C; Ergun MA; Huang H; Berry DA; Mandelblatt JS
JAMA; 2018 Jan; 319(2):154-164. PubMed ID: 29318276
[TBL] [Abstract][Full Text] [Related]
3. A Molecular Subtype-Specific Stochastic Simulation Model of US Breast Cancer Incidence, Survival, and Mortality Trends from 1975 to 2010.
Munoz DF; Xu C; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):89S-98S. PubMed ID: 29554473
[TBL] [Abstract][Full Text] [Related]
4. Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment.
Munoz DF; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):32S-43S. PubMed ID: 29554464
[TBL] [Abstract][Full Text] [Related]
5. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.
Munoz D; Near AM; van Ravesteyn NT; Lee SJ; Schechter CB; Alagoz O; Berry DA; Burnside ES; Chang Y; Chisholm G; de Koning HJ; Ali Ergun M; Heijnsdijk EA; Huang H; Stout NK; Sprague BL; Trentham-Dietz A; Mandelblatt JS; Plevritis SK
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25255803
[TBL] [Abstract][Full Text] [Related]
6. A Bayesian Simulation Model for Breast Cancer Screening, Incidence, Treatment, and Mortality.
Huang X; Li Y; Song J; Berry DA
Med Decis Making; 2018 Apr; 38(1_suppl):78S-88S. PubMed ID: 28627297
[TBL] [Abstract][Full Text] [Related]
7. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.
Jatoi I; Chen BE; Anderson WF; Rosenberg PS
J Clin Oncol; 2007 May; 25(13):1683-90. PubMed ID: 17404367
[TBL] [Abstract][Full Text] [Related]
9. Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49.
van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Huang H; Ergun MA; Burnside ES; Xu C; Li Y; Alagoz O; Lee SJ; Stout NK; Song J; Trentham-Dietz A; Plevritis SK; Moss SM; de Koning HJ
Med Decis Making; 2018 Apr; 38(1_suppl):140S-150S. PubMed ID: 29554468
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP; Geuzinge HA; Stout NK; Alagoz O; Hampton J; Kerlikowske K; de Koning HJ; Miglioretti DL; van Ravesteyn NT; Schechter C; Sprague BL; Tosteson ANA; Trentham-Dietz A; Weaver D; Yaffe MJ; Yeh JM; Couch FJ; Hu C; Kraft P; Polley EC; Mandelblatt JS; Kurian AW; Robson ME;
JAMA Oncol; 2022 Apr; 8(4):587-596. PubMed ID: 35175286
[TBL] [Abstract][Full Text] [Related]
11. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
12. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
[TBL] [Abstract][Full Text] [Related]
13. Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.
van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Cevik M; Schechter CB; Lee SJ; Huang H; Li Y; Munoz DF; Plevritis SK; de Koning HJ; Stout NK; van Ballegooijen M
Med Decis Making; 2018 Apr; 38(1_suppl):112S-125S. PubMed ID: 29554471
[TBL] [Abstract][Full Text] [Related]
14. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Screening, Incidence, and Mortality Across US Counties.
Harding C; Pompei F; Burmistrov D; Welch HG; Abebe R; Wilson R
JAMA Intern Med; 2015 Sep; 175(9):1483-9. PubMed ID: 26147578
[TBL] [Abstract][Full Text] [Related]
16. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
17. Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density.
Lowry KP; Coley RY; Miglioretti DL; Kerlikowske K; Henderson LM; Onega T; Sprague BL; Lee JM; Herschorn S; Tosteson ANA; Rauscher G; Lee CI
JAMA Netw Open; 2020 Jul; 3(7):e2011792. PubMed ID: 32721031
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)-Positive Breast Cancer.
Kunst N; Wang SY; Hood A; Mougalian SS; DiGiovanna MP; Adelson K; Pusztai L
JAMA Netw Open; 2020 Nov; 3(11):e2027074. PubMed ID: 33226431
[TBL] [Abstract][Full Text] [Related]
19. Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.
Mandelblatt JS; Near AM; Miglioretti DL; Munoz D; Sprague BL; Trentham-Dietz A; Gangnon R; Kurian AW; Weedon-Fekjaer H; Cronin KA; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):9S-23S. PubMed ID: 29554466
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
